Education
About Us
Working with TipRanks
Follow Us
Eastgate Biotech Corp (ETBI)
OTHER OTC:ETBI
Total Valuation
Eastgate Biotech has a market cap or net worth of $10.16M. The enterprise value is ―.
Market Cap$10.16M
Enterprise Value―
Share Statistics
Eastgate Biotech has 2,057,546,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,057,546,000
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Eastgate Biotech’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Eastgate Biotech is 0.00. Eastgate Biotech’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio12.17
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Eastgate Biotech had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.75M and capital expenditures 0.00, giving a free cash flow of -420.87K billion.
Operating Cash Flow-1.75M
Free Cash Flow-420.87K
Free Cash Flow per Share>-0.01
Dividends & Yields
Eastgate Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-5171.86
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)2.40K
Important Dates
Eastgate Biotech upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Eastgate Biotech as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Eastgate Biotech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Eastgate Biotech EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Eastgate Biotech has $4.91K in cash and marketable securities with $536.17K in debt, giving a net cash position of $3.07M billion.
Cash & Marketable Securities$4.91K
Total Debt$536.17K
Net Cash$3.07M
Net Cash Per Share<$0.01
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Eastgate Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―